Literature DB >> 25173485

Immunoglobulin and cytokine changes induced following immunization with a DNA vaccine encoding Toxoplasma gondii selenium-dependent glutathione reductase protein.

Ibrahim A Hassan1, Shuai Wang1, LiXin Xu1, RuoFeng Yan1, XiaoKai Song1, XiangRui Li2.   

Abstract

Toxoplasma gondii Glutathione Reductase (TgGR) plays important role during the survival of the parasite. In this investigation, immunological changes and protection efficiency of this protein delivered as a DNA vaccine (pTgGR) have been evaluated. Mice were immunized with pTgGR, followed by challenge with virulent T. gondii RH strain, 2 weeks after the booster immunization. Compared to the control groups pVAX1, PBS and Blank groups, the results showed that pTgGR stimulated specific humoral response defined by significant titers of total IgG, subclasses IgG1 and IgG2a, classes IgA and IgM, but not IgE. Analysis of IFN-γ, IL-4, IL-17 and TGF-β1 cytokines after immunization and compared with the control groups showed significant increments in pTgGR group. Additionally, T lymphocytes subpopulation CD4(+) T was positively recruited with significant percentage detected, while subset CD8(+) appeared not to be involved in response to this antigen. Vaccinated mice showed a significantly longer survival time, 15 days, in contrast with control groups which died within 8-10 days after challenge. These results demonstrated that TgGR could induce significant humoral and cell mediated responses leading to a considerable level of resistance against toxoplasmosis infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA vaccines; Selenium; TgGR; Toxoplasma gondii

Mesh:

Substances:

Year:  2014        PMID: 25173485     DOI: 10.1016/j.exppara.2014.08.011

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  9 in total

Review 1.  REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII.

Authors:  Rosalie C Warner; Ryan C Chapman; Brianna N Davis; Paul H Davis
Journal:  J Parasitol       Date:  2021-11-01       Impact factor: 1.276

2.  Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice.

Authors:  Ragab M Fereig; Yasuhiro Kuroda; Mohamad Alaa Terkawi; Motamed Elsayed Mahmoud; Yoshifumi Nishikawa
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

3.  Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis.

Authors:  Shuai Wang; Zhenchao Zhang; Yujian Wang; Javaid A Gadahi; Lixin Xu; Ruofeng Yan; Xiaokai Song; Xiangrui Li
Journal:  Front Microbiol       Date:  2017-02-13       Impact factor: 5.640

Review 4.  Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential.

Authors:  Sajad Rashidi; Celia Fernández-Rubio; Reza Mansouri; Mohammad Ali-Hassanzadeh; Esmaeel Ghani; Mohammadreza Karimazar; Raúl Manzano-Román; Paul Nguewa
Journal:  Parasitol Res       Date:  2022-01-06       Impact factor: 2.289

5.  Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant.

Authors:  Zhengqing Yu; Wenxi Ding; Muhammad Tahir Aleem; Junzhi Su; Junlong Liu; Jianxun Luo; Ruofeng Yan; Lixin Xu; Xiaokai Song; Xiangrui Li
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

6.  Seroprevalence of Toxoplasma gondii infection among patients with hand, foot and mouth disease in Henan, China: a hospital-based study.

Authors:  Shuai Wang; Chunwei Lan; Luwen Zhang; Haizhu Zhang; Zhijun Yao; Dong Wang; Jingbo Ma; Jiarong Deng; Shiguo Liu
Journal:  Infect Dis Poverty       Date:  2015-12-10       Impact factor: 4.520

7.  Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.

Authors:  Shuai Wang; YuJian Wang; XiaoNi Sun; ZhenChao Zhang; TingQi Liu; Javaid Ali Gadahi; Ibrahim Adam Hassan; LiXin Xu; RuoFeng Yan; XiaoKai Song; XiangRui Li
Journal:  BMC Infect Dis       Date:  2015-10-24       Impact factor: 3.090

Review 8.  Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine.

Authors:  Masoud Foroutan; Fatemeh Ghaffarifar
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29

9.  Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis.

Authors:  Zhenchao Zhang; Yuhua Li; Mingyong Wang; Qing Xie; Pengju Li; Suqiong Zuo; Lingmin Kong; Chenxing Wang; Shuai Wang
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.